Press release
Glaucoma Market Expected to Reach USD 15.0 Billion by 2034
Glaucoma
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72285
The global glaucoma market is experiencing growth as aging populations expand, early screening improves, and new treatments such as minimally invasive glaucoma surgery (MIGS), sustained-release implants, and AI-based diagnostic tools gain traction.
Market Overview
• Market Size (2024): USD 7.2 billion
• Forecast (2034): USD 15.0 billion
• CAGR (2025-2034): 7.5%
Key Highlights:
• Over 76 million people worldwide are estimated to have glaucoma in 2024, projected to exceed 110 million by 2040.
• Rising adoption of sustained-release and long-acting intraocular implants to improve compliance.
• Strong momentum for MIGS (minimally invasive glaucoma surgery) as a safer alternative to trabeculectomy.
• Growing integration of AI-based retinal imaging and tele-ophthalmology in early detection.
Segmentation Analysis
By Disease Type:
• Primary Open-Angle Glaucoma (largest share)
• Angle-Closure Glaucoma
• Secondary Glaucoma (traumatic, uveitic, steroid-induced, neovascular)
• Congenital Glaucoma
By Treatment Type:
• Medications
o Prostaglandin Analogs (first-line)
o Beta-Blockers
o Alpha-Agonists
o Carbonic Anhydrase Inhibitors
o Combination Drugs
• Laser Therapies
o Selective Laser Trabeculoplasty (SLT)
o Argon Laser Trabeculoplasty (ALT)
• Surgical Interventions
o Trabeculectomy
o Glaucoma Drainage Devices
o Minimally Invasive Glaucoma Surgery (MIGS - fastest growing)
• Sustained-Release Drug Delivery Systems
o Implants (bimatoprost SR, dexamethasone, fluocinolone)
o Injectable depot formulations
By End Use:
• Hospitals & Specialty Eye Clinics
• Ambulatory Surgical Centers
• Retail & Online Pharmacies
Segmentation Summary:
Drug therapies dominate the market today, but MIGS and sustained-release implants are the fastest-growing segments, driven by demand for better compliance and safety.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72285/glaucoma-market
Regional Analysis
North America
• Largest market (~42% share in 2024).
• Strong adoption of MIGS devices and sustained-release implants.
• High awareness and screening programs driving early diagnosis.
Europe
• ~30% share.
• Germany, UK, and France leading innovation in surgical glaucoma care.
• Increasing use of combination therapies and government support for screening.
Asia-Pacific
• Fastest-growing region, CAGR ~8.9%.
• High patient pool, particularly in China and India.
• Rising prevalence due to aging populations and diabetes.
• Expanding ophthalmology infrastructure and gradual adoption of MIGS.
Latin America
• Brazil and Mexico improving access to surgical and pharmacological options.
Middle East & Africa
• GCC nations advancing specialty eye care.
• Large unmet need in most African countries due to underdiagnosis.
Regional Summary:
North America and Europe dominate today, while Asia-Pacific shows the strongest growth trajectory, with rising prevalence and healthcare investments.
Market Dynamics
Key Growth Drivers:
• Growing aging populations worldwide.
• Rising incidence of diabetes and hypertension, risk factors for glaucoma.
• Increased adoption of long-acting therapies and surgical innovations.
• Expanding global awareness and screening programs.
Key Challenges:
• Poor adherence to daily eye drop regimens.
• High treatment costs of MIGS and implants.
• Underdiagnosis in low- and middle-income countries.
• Irreversibility of vision loss once advanced.
Latest Trends:
• Growth of home-based IOP monitoring devices.
• Development of gene therapy and neuroprotective drugs.
• Integration of AI-driven retinal imaging for early detection.
• Expansion of combination therapies to improve efficacy and compliance.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72285
Competitor Analysis
Major Players in the Market:
• Novartis AG (Alcon - glaucoma portfolio)
• AbbVie Inc. (Allergan - Lumigan, Combigan)
• Santen Pharmaceutical Co., Ltd.
• Bausch + Lomb
• Johnson & Johnson Vision (MIGS devices)
• Glaukos Corporation (iStent, MIGS pioneer)
• Iridex Corporation (laser systems)
• Regeneron Pharmaceuticals, Inc.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
Competitive Summary:
AbbVie and Novartis dominate glaucoma drugs, while Glaukos and J&J Vision lead the MIGS market. Bausch and Santen provide strong global portfolios, while emerging biotech players explore neuroprotective and gene therapies. Competition is increasingly centered on long-acting, compliance-friendly solutions.
Conclusion
The Glaucoma Market, valued at USD 7.2 billion in 2024, is projected to reach USD 15.0 billion by 2034, growing at a CAGR of 7.5%.
Key Takeaways:
• Medications remain dominant but MIGS and sustained-release implants are the fastest-growing segments.
• North America and Europe lead today, while Asia-Pacific will see the highest growth.
• AI diagnostics, neuroprotective therapies, and gene therapy are future game-changers.
• Public health initiatives for screening will reduce late-stage diagnoses.
The next decade will see glaucoma management evolve from short-term pressure reduction to long-acting, precision-based, and potentially neuroprotective strategies, offering patients better vision outcomes and reduced blindness risk worldwide.
This report is also available in the following languages : Japanese (緑内障市場), Korean (녹내장 시장), Chinese (青光眼市场), French (Marché du glaucome), German (Glaukommarkt), and Italian (Mercato del glaucoma), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72285/glaucoma-market#request-a-sample
Our More Reports:
Bronchial Spasm Market
https://exactitudeconsultancy.com/reports/72851/bronchial-spasm-market
Neuroendocrine Breast Tumor Market
https://exactitudeconsultancy.com/reports/72852/neuroendocrine-breast-tumor-market
Porphyria Targeting Therapies Market
https://exactitudeconsultancy.com/reports/72853/porphyria-targeting-therapies-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glaucoma Market Expected to Reach USD 15.0 Billion by 2034 here
News-ID: 4194043 • Views: …
More Releases from Exactitude Consultancy
Neurotrophic Keratitis Patient Pool Analysis Market Forecast to Grow at 8.2% CAG …
Introduction
Neurotrophic keratitis (NK) is a rare, degenerative corneal disease caused by impaired corneal innervation, leading to reduced or absent corneal sensitivity. This results in poor wound healing, epithelial breakdown, and in severe cases, corneal ulceration, scarring, and vision loss. Although classified as a rare disease, NK has a significant clinical impact due to its association with conditions such as herpes simplex virus (HSV) keratitis, herpes zoster ophthalmicus, diabetes, ocular surgeries,…
Dry Age-Related Macular Degeneration Patient Pool Analysis Market Projected to G …
Introduction
Dry age-related macular degeneration (Dry AMD) is a chronic, progressive eye disorder that damages the macula-the central portion of the retina responsible for sharp, straight-ahead vision. Unlike wet AMD, which involves abnormal blood vessel growth, dry AMD is characterized by the accumulation of drusen (yellow deposits) beneath the retina and gradual thinning of macular tissues. While it progresses more slowly, Dry AMD accounts for nearly 85-90% of all AMD cases…
Night Vision Disturbances Market Forecast to Grow at 6.8% CAGR
Introduction
Night vision disturbances (NVD) encompass a range of visual impairments that occur under low-light conditions, such as halos, glare, starbursts, and difficulty seeing in dim environments. These disturbances can be associated with refractive errors, cataracts, corneal diseases, retinal disorders, or post-surgical complications such as LASIK and intraocular lens (IOL) implantation. While often underreported, NVD significantly affects quality of life by impairing driving ability, mobility, and overall visual confidence.
With global aging…
Hyperopia Market is projected to reach USD 13.7 billion by 2034
Hyperopia, also known as farsightedness, is a common refractive error where distant objects are seen more clearly than near ones. It occurs due to the short axial length of the eye or abnormal corneal curvature, causing light to focus behind the retina. Symptoms include eye strain, blurred near vision, headaches, and difficulty with reading or prolonged near work.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72287
The growing global demand…
More Releases for Glaucoma
Glaucoma Surgery Devices Market Report 2024 - Glaucoma Surgery Devices Market Si …
"The Business Research Company recently released a comprehensive report on the Global Glaucoma Surgery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The glaucoma surgery devices…
Global Glaucoma Market
According to a new market research report published by Global Market Estimates, the Global Glaucoma Market is projected to grow at a CAGR value of 5.0% from 2023 to 2028.
Growing awareness for early diagnosis of glaucoma have gained prominence due to various educational campaigns and screening programs. Early detection allows for timely intervention, leading to better disease management and reducing the risk of vision loss, thus propelling the market growth.…
Glaucoma Treatment Market - Safeguarding Sight: Innovating Glaucoma Treatment fo …
Newark, New Castle, USA: The "Glaucoma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Glaucoma Treatment Market: https://www.growthplusreports.com/report/glaucoma-treatment-market/8926
This latest report researches the industry structure, sales, revenue,…
Glaucoma Surgical Devices Market By Device Type (Glaucoma Drainage Devices, Impl …
Glaucoma Surgical Devices market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain…
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the…
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide.
Sudden increase in the aging population and…
